Medtronic: Diabetes Mellitus, Type 1 trials

The registry lists 55 Diabetes Mellitus, Type 1 studies with Medtronic as lead sponsor. 3 are open to participants now and 39 have results posted.

Phase 3 2Phase 4 3No phase 50(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 DiabetesRecruitingNCT07864168Not applicable
• Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 DiabetesNot yet recruitingNCT07401901Not applicable
• Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)RecruitingNCT06739811Not applicable
• Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGMCompletedNCT05714059Not applicableResults posted
• Evaluation of the MiniMed 780 System in Paediatric SubjectsCompletedNCT05574062Not applicableResults posted
• Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®CompletedNCT05325294Not applicableResults posted
• Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®CompletedNCT05224258Not applicableResults posted
• Evaluation of Meal Gesture Dosing in Adults With Type 1 DiabetesCompletedNCT04964128Not applicableResults posted
• Use of the Guardian™ Connect System With Smart Connected DevicesCompletedNCT04809285Not applicableResults posted
• MiniMed™ 670G System China Study for Type I DiabeticCompletedNCT04663295Not applicableResults posted
• Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and PediatricsCompletedNCT04436822Not applicableResults posted
• Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in AdultsCompletedNCT04378114Not applicableResults posted
• The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.CompletedNCT04308291Results posted
• ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 DiabetesCompletedNCT04235504Not applicableResults posted
• Feasibility Studies of Personalized Closed LoopCompletedNCT04203823Not applicableResults posted
• Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and PediatricsCompletedNCT03966911Not applicableResults posted
• Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) SystemCompletedNCT03959423Not applicableResults posted
• Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at HomeCompletedNCT02748018Not applicableResults posted
• Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 DiabetesCompletedNCT02733991Not applicableResults posted
• Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 DiabetesCompletedNCT02660827Not applicableResults posted
• Qingdao: Insulin Pump Follow-Up ProgramTerminatedNCT02655666Results posted
• Hybrid Closed Loop Pivotal Trial in Type 1 DiabetesCompletedNCT02463097Not applicableResults posted
• Adult Accuracy Study of the Enlite 3 Glucose SensorCompletedNCT02246582Not applicableResults posted
• In Clinic Evaluation of the PLGM FeatureCompletedNCT02130284Not applicableResults posted
• Threshold Suspend in Pediatrics at HomeCompletedNCT02120794Not applicableResults posted
• Overnight Closed Loop Study in U.S.CompletedNCT01857973Not applicableResults posted
• Orchestra Pregnancy Observational Study in PolandCompletedNCT01779141Results posted
• Registry of Use and Application of Sensor Augmented Pump (SAP) Therapy Under Daily Life ConditionsCompletedNCT01718522Results posted
• Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend FeatureCompletedNCT01497938Phase 3Results posted
• A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of UseCompletedNCT01464346Not applicableResults posted
• United Kingdom User Evaluation, MiniMed Paradigm® X54 SystemCompletedNCT01267175Phase 4Results posted
• New Glucose Sensor PediatricCompletedNCT01161043Not applicableResults posted
• Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 SystemCompletedNCT01148862Not applicableResults posted
• An Inpatient Performance Evaluation of a New Subcutaneous Glucose SensorCompletedNCT01112696Not applicableResults posted
• Effect of Closed Loop Glucose Control on Exercise-Associated HypoglycemiaCompletedNCT00831389Not applicableResults posted
• INTERPRET - International Report on Routine Practice of Sensor-enabled Pump TherapyCompletedNCT00790088Results posted
• SWITCH - Sensing With Insulin Pump Therapy to Control HbA1cCompletedNCT00598663Not applicableResults posted
• Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate EffectivenessCompletedNCT00530023Phase 4Results posted
• Obtain a Good Blood Glucose Control With the Paradigm Real Time SystemCompletedNCT00441129Not applicableResults posted
• Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump TherapyCompletedNCT00417989Not applicableResults posted
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin AdministrationCompletedNCT00211536Phase 3Results posted
• Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 DiabetesCompletedNCT00211510Not applicableResults posted
• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesActive, not recruitingNCT07228117Not applicable
• SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesWithdrawnNCT06719531Not applicable
• Smart MDI Study (CIP343)CompletedNCT06645834Not applicable
• Safety Evaluation of MiniMed™ 780G System With DS5 CGM in ChildrenCompletedNCT06604871Not applicable
• InPen User ExperienceCompletedNCT05029271Not applicable
• Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 DiabetesWithdrawnNCT02692547Not applicable
• A Performance Evaluation of the Enlite 3 SensorWithdrawnNCT02649010Not applicable
• A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and PediatricsWithdrawnNCT02646878Not applicable
• A Performance Evaluation of the Harmony 1 Sensors in Adults and PediatricsWithdrawnNCT02456922Not applicable
• Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4Status unknownNCT01775059Not applicable
• Feasibility Study of an Integrated Sensor and Infusion SetCompletedNCT01770561Not applicable
• Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight PeriodCompletedNCT01712594Not applicable
• Effectiveness Study of the Guardian RT in Type 1 DiabeticsCompletedNCT01331343Phase 4